Opportunity
Simpler Grants.gov #RFA-DK-27-121
NIH Seeks Clinical Centers for Youth Anti-Obesity Medication Research Consortium
Buyer
National Institutes of Health
Posted
August 28, 2025
Respond By
December 01, 2026
Identifier
RFA-DK-27-121
NAICS
541715
The National Institutes of Health (NIH) is seeking clinical centers to join a consortium focused on optimizing anti-obesity medication (AOM) strategies for children and adolescents. - Government Buyer: - National Institutes of Health (NIH) - Products/Services Requested: - Clinical research participation as a consortium member - Activities include protocol development, use of common data elements, centralized laboratory procedures, and collaborative data analysis - Focus on testing AOM initiation, dosage, frequency, adjunct lifestyle therapies, and predictors of treatment response - Unique/Notable Requirements: - Consortium model with shared protocol and data standards - Open to a wide range of eligible applicants (government, academia, nonprofits, businesses) - No specific OEMs or vendors required, as this is a research grant opportunity - OEMs: - No OEMs or product manufacturers are specified, as this is not a product procurement
Description
This Notice of Funding Opportunity invites applications from clinical centers to participate in a consortium to test anti-obesity medication treatment strategies for youth with obesity. The goal is to maximize benefits and minimize risks of AOM use while supporting healthy growth, nutritional status, mental health, and quality of life. Priority areas include determining optimal developmental stage for AOM initiation, weight loss parameters, medication class and dosage, and adjunct lifestyle therapies. The consortium will collaborate on protocol development, data collection, and analysis for independent or multicenter trials.